Evidence map›Paper›PMID 42879113›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

SEOM-GGCC clinical guidelines for the prophylaxis of infectious diseases in patients with cancer (UPDATE 2026).

Isabel Echavarria, Jesús Corral, María Pilar Diz Taín, Fernando Henao Carrasco, Vega Iranzo González-Cruz, Xabier Mielgo-Rubio, Teresa Quintanar, Carlos Rivas Corredor, Pedro Pérez Segura

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isabel EchavarriaDepartment of Medical Oncology, Hospital General Universitario Gregorio Marañon, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Madrid, Spain. iechavarriadg@gmail.com.ORCID http://orcid.org/0000-0002-1156-7681
Jesús CorralDepartment of Oncology, Hospital Universitario de Jerez de La Frontera, Cádiz, Spain.
María Pilar Diz TaínDepartment of Medical Oncology, Hospital Universitario de León, León, Spain.
Fernando Henao CarrascoDepartment of Medical Oncology, Hospital Universitario Virgen Macarena, Seville, Spain.
Vega Iranzo González-CruzDepartment of Medical Oncology, Consorcio Hospital General Universitario de Valencia, Department of Medicine, Universitat de València, Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Valencia, Spain.
Xabier Mielgo-RubioDepartment of Medical Oncology, Hospital Universitario Cruces, Bilbao, Spain.
Teresa QuintanarBiobizkaia Health Research Institute, Barakaldo, Bilbao, Bizkaia, Spain.
Carlos Rivas CorredorDepartment of Medical Oncology, Hospital General Universitario de Elche, Elche, Spain.
Pedro Pérez SeguraDepartment of Medical Oncology, Hospital de Mataró, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections are still a major cause of morbidity and mortality in patients with cancer. Some of these infections are preventable through specific measures, such as vaccination or prophylaxis. This guideline (updated in 2026) aims to summarize the current evidence and recommendations for the prevention of infections in patients with cancer, devoting special attention to the most prevalent preventable infectious diseases. All of the evidence is graded according to The Infectious Diseases Society of America grading system.

Indexed as

ChemotherapyImmunosuppressionProphylaxisVaccination

Identifiers

PMID42879113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.